WithdrawnPhase 2/3

Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test

Stopped: I have found it is quite difficult to conduct the work without changing some detail in original protocol. So we would like to re-start the study again with some modification.

Thailand0Started 2023-11-30

Plain-language summary

To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who have low-grade abnormality result such as ASC-US, LSIL, HPV 16/18 positive, persistent HPV infection after cervical cancer screening test * No history of endometrial or cervical cancer * Pregnancy test negative * Good communication in Thai language * Vouluntarily participate to the study Exclusion Criteria: * Pregnancy test positive after participate in the study * Pathologic result from colposcopic biopsy (before intervention) is high-grade abnormality such as HSIL, CIN2-3 or AIS

What they're measuring

Number of participants with cytologic examination, HPV testing and colposcopic examination with biopsy ( Efficacy of 95%Trichloroacetic acid in the treatment of CIN1 or less)

Timeframe: 6 months after intervention

Trial details

NCT IDNCT06188104

SponsorDepartment of Medical Services Ministry of Public Health of Thailand

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More CIN1 trials